MACKOOL ONLINE CME

CME SERIES | SURGICAL VIDEOS

Supported by an unrestricted independent medical educational grant from Alcon
Commercially supported by Glaukos, MST, and Crestpoint Management
In kind support by Sony Healthcare Solutions</span

EPISODE 78 June 2022

Cataract-IOL in an Aniridic Eye: The Artificial Iris

Satisfactory completion: Learners must pass a post-test and complete an evaluation form to receive a certificate of completion. Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.
Accreditation Statement - In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Review Education Group. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians (ACCME) Credit Designation - Amedco LLC designates this enduring material activity for a maximum of .25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Target Audience: Ophthalmologists with an interest in cataract surgery.
Learning Objectives: After completion of this educational activity, participants should be able to demonstrate the technique and discuss the indication for implantation of an artificial iris at the time of cataract-implant surgery.
Contact Information: If you have questions regarding any of the surgical videos, please contact us at kmccarthy@postgradhealthed.com
All rights reserved. Video used with permission.

Episode 78: A patient with congenital aniridia undergoes phacoemulsification, IOL insertion, and insertion of an artificial iris device.

Financial Disclosure: Richard J. Mackool, MD & RJ Mackool, MD: Consultant: Alcon; Patent Holder: Crestpoint Management

TOP